Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
Publisher： Karger
E-ISSN： 1421-9824|37|3-4|232-245
ISSN： 1420-8008
Source： Dementia and Geriatric Cognitive Disorders, Vol.37, Iss.3-4, 2013-11, pp. : 232-245
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
